Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.
Geschäft · 24.4.19961 Min. Lesezeit
Personal Blood Storage of Memphis, Inc.; Opportunity for Hearing on a Proposal to Revoke U.S. License No. 1131
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The Food and Drug Administration (FDA) is announcing an opportunity for a hearing on a proposal to revoke the establishment license (U.S. License No. 1131) and the product licenses issued to Personal Blood Storage of Memphis, Inc., for the manufacture of Whole Blood, Red Blood Cells, Plasma, and Platelets. The proposed revocation is based on the establishment's discontinuing of manufacturing of products to the extent that a meaningful inspection or evaluation cannot be made.
Originalsprache der Quelle: Federal Register — Food and Drug AdministrationOriginalquelle öffnen →